All AbMole products are for research use only, cannot be used for human consumption.
Flumazenil is a competitive GABAA receptor antagonist, used in the treatment of benzodiazepine overdoses.
Patent. CN112137996B 2023 Aug 25.
Patent. CN112137996B
Flumazenil purchased from AbMole
| Molecular Weight | 303.29 |
| Formula | C15H14FN3O3 |
| CAS Number | 78755-81-4 |
| Solubility (25°C) | 10 mM in DMSO |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related GABA Receptor Products |
|---|
| SKF 89976A hydrochloride
SKF 89976A hydrochloride is a potent GABA uptake inhibitor, selective for GAT-1. |
| Alpidem
Alpidem is a potent antagonist of peripheral benzodiazepine receptor (PBR). |
| (R)-Baclofen
(R)-baclofen, a gamma-aminobutyric acid derivative and agonist at GABA-B receptors, inhibits nerve conduction in the central nervous system and can be used in studies related to spasticity. |
| (+)-Bicuculline
(+)-Bicuculline is a competitive antagonist of GABAA receptors with IC50 of 2 μM, also blocks Ca(2+)-activated potassium channels. |
| Bemegride
Bemegride is a central nervous system stimulant and antidote for barbiturate poisoning. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
